Cite
HARVARD Citation
Costa Neto, A. et al. (2020). FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients. Transfusion. 60 (7), pp. 1573-1578. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Costa Neto, A. et al. (2020). FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients. Transfusion. 60 (7), pp. 1573-1578. [Online].